Breast Cancer

Compounds that prevent protein aggregation may lead to therapy for conditions such as cancer and diabetes.

Scalp cooling technology seeks to ensure hair retention in most instances.

Teikoku Pharma USA has submitted a New Drug Application to the FDA for the product.

Costs have risen 120% in aggregate since 1995.

Errors in genes may leave tumors susceptible to PARP inhibitors.

Risk of sudden onset menopause reduced by adding goserelin to chemotherapy regimen.

Survivors of breast cancer more likely to develop aggressive form of thyroid cancer.

Study finds depression in African American cancer patients has gone under-recognized.

Economic variables impact breast cancer treatment, study finds.

Supplemental oxygenation may shrink tumors and enhance cancer immunotherapy.

Study argues for more balanced information for patients before making a treatment decision.

Better chemotherapy drugs lead to increased usage prior to breast operations over last 5 years.

Compound can monitor biochemical processes involved with protein kinases.

Many physicians still use technique that fails to detect deep tissue lesions near the chest wall.

Study reveals optimistic findings for patients without other options for targeted cancer therapy.

Study finds fewer women would support less frequent screening if they were found to be at lower risk.

Delivery system kills chemotherapy-resistant cancer stem cells and prevents secondary tumor formation.

Company again selected as limited distribution pharmacy provider.

Study examines how side effects from commonly used antibiotics effect mitochondria of cancer cells.

Palbociclib inhibits molecules that promote cancer cell growth.

The FDA today granted accelerated approval to a drug that treats breast cancer in postmenopausal women by attacking molecules that promote cancer cell growth.

Technology locates tumors otherwise obscured by dense breast tissue on a mammogram.

Repurposing drugs that block sodium channels may offer a novel therapy for cancer.

Benefits of tamoxifen varies among patients.

Eribulin evaluated for the first time as an early metastatic breast cancer treatment.